OR5BN2P

Across TCGA pan-cancer cohorts, OR5BN2P RNA is linked to patient survival in 4 of 34 cancer types, making it the most broadly survival-associated OR5BN2P data layer.

The strongest signal is observed in uveal melanoma (UVM), where higher OR5BN2P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated OR5BN2P expression acts as an unfavorable survival marker.

UVM, KIRC, and GBM are the cancer types where OR5BN2P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UVM	OS	Tertile	All	0.037	0.858	<.001	108	view →
KIRC	DFS	Tertile	III,IV	0.127	0.744	.002	72	view →
GBM	DFS	Tertile	All	0.031	0.257	<.001	18	view →
PRAD	DFS	Tertile	All	0.553	0.935	.015	18	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

OR5BN2P–UVM (OS)

Open the UVM breakdown →